Antibiotic-resistant Salmonella worries experts

NewsGuard 100/100 Score

According to an international team of researchers a strain of Salmonella that is resistant to important antibiotics has spread from Africa to Europe in recent years and has been spotted in a few samples of imported spices in the United States.

The new strain is a variant of Samonella enterica serotype Kentucky and has caused illness in 489 people in three European countries between 2002 and 2008, many of whom had travelled to North Africa or the Middle East says the report published today in Clinical Infectious Diseases. The pathogen was detected increasingly often over that period, it says.

The new strain is also resistant to several antimicrobials and shows high-level resistance to ciprofloxacin, a member of the fluoroquinolone class, which is important for treating severe Salmonella infections, the report says. In fact the study began with the detection of ciprofloxacin-resistant Salmonella Kentucky infections in 17 French travellers who had visited eastern or north-eastern Africa from 2002 to 2005. The researchers gathered Salmonella surveillance data from France, England and Wales, Denmark, and the United States for the period 2002 through 2008 and ran molecular analyses on isolates from these countries and from possible source countries.

Results revealed that 200 ciprofloxacin-resistant Salmonella Kentucky isolates were reported in France, 244 in England and Wales, and 45 in Denmark, for a total of 489. In the United States, 679 Salmonella Kentucky isolates were reported to the US Centers for Disease Control and Prevention (CDC) during the study period, but just 23 of these were submitted to the National Antimicrobial Resistance Monitoring System, and none of these were ciprofloxacin-resistant. However, using the US PulseNet database of pulsed-field gel electrophoresis (PFGE, or DNA fingerprint) data for Salmonella Kentucky isolates, the researchers found five isolates similar to the strain they were looking for, isolated from spices imported from North Africa during 2002 to 2009. Three of these were ciprofloxacin-resistant.

This resistant strain is also found to be growing more common over the study period, with just 3 isolates identified in 2002 and 174 in 2008. Travel information was available for 307 of the 489 patients, and it showed that 89% of them had traveled to Africa or Asia in the 15 days before their illness. Morocco and Egypt were the leading destinations by far. Genetic studies led to the conclusion that all the human isolates belonged to a single clone characterized by certain multi-locus sequencing and PFGE patterns and the presence of a particular “genomic island.” They dubbed it ST198-X1 (ciprofloxacin-resistant).

The authors conclude that the ancestor of this variant first appeared in the 1990s in Egypt, where it infected humans and acquired resistance determinants. They report that the strain has been found in poultry in Ethiopia, Morocco, and Nigeria, and they speculate that the widespread use of fluoroquinolones in chicken and turkey production in Nigeria and Morocco might have contributed to its spread.

Other antibiotic resistant strains include those for amoxicillin, streptomycin, spectinomycin, gentamicin, sulfamethoxazole, and tetracycline. “The current emergence of ST198-X1… highlights the need to set up a global integrated national surveillance system for humans and all sectors of the food production chain, focused on the main food borne pathogens in Africa,” the authors conclude.

In an accompanying commentary, food borne disease expert Craig W. Hedberg, of the University of Minnesota's School of Public Health, writes that the study demonstrates “the power and importance of linking public health surveillance systems on an international level.” “The emergence of multidrug-resistant S. Kentucky was identified before the clone spread to poultry flocks in Europe or the United States…Producers and regulators can now look for these strains and rapidly respond to their presence,” Hedberg said. Further, he writes that the spread of the resistant variant “could be a major public health threat, similar to the earlier emergence and global dissemination of Salmonella typhimurium DT104.” Hedberg also commented that “visionary and strong political leadership” is needed to maintain public health surveillance in the current era of budget-cutting.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2018, August 23). Antibiotic-resistant Salmonella worries experts. News-Medical. Retrieved on May 17, 2024 from https://www.news-medical.net/news/20110804/Antibiotic-resistant-Salmonella-worries-experts.aspx.

  • MLA

    Mandal, Ananya. "Antibiotic-resistant Salmonella worries experts". News-Medical. 17 May 2024. <https://www.news-medical.net/news/20110804/Antibiotic-resistant-Salmonella-worries-experts.aspx>.

  • Chicago

    Mandal, Ananya. "Antibiotic-resistant Salmonella worries experts". News-Medical. https://www.news-medical.net/news/20110804/Antibiotic-resistant-Salmonella-worries-experts.aspx. (accessed May 17, 2024).

  • Harvard

    Mandal, Ananya. 2018. Antibiotic-resistant Salmonella worries experts. News-Medical, viewed 17 May 2024, https://www.news-medical.net/news/20110804/Antibiotic-resistant-Salmonella-worries-experts.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
£85 million funding to support the international community in tackling antimicrobial resistance